187 related articles for article (PubMed ID: 1761736)
1. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
2. The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
Sakai H; Kobayashi S; Hamada K; Iida S; Akita H; Tanaka E; Uchida E; Yasuhara H
Br J Clin Pharmacol; 1991 Mar; 31(3):353-5. PubMed ID: 2054276
[TBL] [Abstract][Full Text] [Related]
3. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
4. Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine.
Carrum G; Egan JM; Abernethy DR
Clin Pharmacol Ther; 1986 Aug; 40(2):140-3. PubMed ID: 3731677
[TBL] [Abstract][Full Text] [Related]
5. The effects of encainide versus diltiazem on the oxidative metabolic pathways of antipyrine.
Bottorff MB; Lalonde RL; Kazierad DJ; Hoon TJ; Tsiu SJ; Mirvis DM
Pharmacotherapy; 1989; 9(5):315-21. PubMed ID: 2510135
[TBL] [Abstract][Full Text] [Related]
6. The effect of roxatidine acetate and cimetidine on hepatic drug clearance assessed by simultaneous administration of three model substrates.
Tanaka E; Nakamura K
Br J Clin Pharmacol; 1989 Aug; 28(2):171-4. PubMed ID: 2570603
[TBL] [Abstract][Full Text] [Related]
7. Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man.
Tanaka E; Nakamura K
Eur J Clin Pharmacol; 1989; 36(6):629-32. PubMed ID: 2776822
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of the effects of isradipine and diltiazem on antipyrine and indocyanine green clearances in elderly volunteers.
Klockowski PM; Lener ME; Sirgo MA; Rocci ML
Clin Pharmacol Ther; 1990 Oct; 48(4):375-80. PubMed ID: 2146057
[TBL] [Abstract][Full Text] [Related]
9. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
[TBL] [Abstract][Full Text] [Related]
10. Physical exercise and improvement of liver oxidative metabolism in the elderly.
Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
[TBL] [Abstract][Full Text] [Related]
11. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
12. Influence of short-term water deprivation on antipyrine disposition in calves.
Janus K; Muszczynski Z; Suszycka J
Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
[TBL] [Abstract][Full Text] [Related]
13. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
14. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
Anadón A; Martinez-Larrañaga MR; Fernandez MC; Diaz MJ; Bringas P
Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
[TBL] [Abstract][Full Text] [Related]
15. Effect of age on the pharmacokinetics of antipyrine in calves.
Janus K; Suszycka J
Res Vet Sci; 1996 May; 60(3):234-7. PubMed ID: 8735513
[TBL] [Abstract][Full Text] [Related]
16. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
[TBL] [Abstract][Full Text] [Related]
17. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
[TBL] [Abstract][Full Text] [Related]
18. Effect of deltamethrin on antipyrine pharmacokinetics and metabolism in rat.
Anadón A; Martinez-Larrañaga MR; Díaz MJ; Bringas P; Fernandez MC
Arch Toxicol; 1991; 65(2):156-9. PubMed ID: 2059156
[TBL] [Abstract][Full Text] [Related]
19. The effect of intravenous pretreatment with small liposomes on the pharmacokinetics and metabolism of antipyrine in rabbits.
Badiola N; Al-Angary AN; Halbert GW
J Pharm Pharmacol; 1992 Apr; 44(4):366-8. PubMed ID: 1355554
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of cytochrome P450 isoforms and peroxisomal proliferation by cyfluthrin in male Wistar rats.
Anadón A; Martínez MA; Martínez M; Castellano V; Ares I; Romero A; Fernández R; Martínez-Larrañaga MR
Toxicol Lett; 2013 Jul; 220(2):135-42. PubMed ID: 23639246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
